484 Impact of 4-weekly capecitabine plus paclitaxel (XP) combination therapy for metastatic breast cancer: a multicenter phase II trial (KBCSG-0609)
D. Yamamoto, T. Taguchi, N. Masuda, T. Nakayama, T. Nagata, M. Nomura, K. Yoshidome, H. Yoshino, J. Sakamoto, S. NoguchiVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70505-x
File:
PDF, 49 KB
english, 2010